Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2008

01.09.2008 | Case Report

Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report

verfasst von: Seiji Kanayama, Yoshihiko Yamada, Shoji Haruta, Katsuhiko Naruse, Naoto Furukawa, Ryuji Kawaguchi, Shozo Yoshida, Mariko Sakata, Toshiyuki Sado, Takashi Kitanaka, Hidekazu Oi, Hiroshi Kobayashi

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Case report

We describe a case of synchronous peritoneal dissemination and multiple lung metastases after surgery for stage IA primary uterine papillary serous carcinoma (UPSC) of the endometrium, revealed by an uncontrollable retention of ascites.

Results and discussion

She was initially treated with a hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy after initial presentation. Tumor recurrence, diagnosed 12 months later, has been treated with six cycles of Paclitaxel 175 mg/m2 and Carboplatin [area under the curve 5 (Calvert Formula)] every 3 weeks and showed an advantage of this regimen. Early recurrences of the stage IA UPSC can occur and continued close surveillance is recommended. We report herein the case about this entity.
Literatur
1.
Zurück zum Zitat Alobaid A, Bruchim I, Verkooijen H, Gauthier P, Petignat P (2006) Adjuvant therapy for patients with stage I papillary serous endometrial cancer. Eur J Surg Oncol 32:358–362PubMedCrossRef Alobaid A, Bruchim I, Verkooijen H, Gauthier P, Petignat P (2006) Adjuvant therapy for patients with stage I papillary serous endometrial cancer. Eur J Surg Oncol 32:358–362PubMedCrossRef
2.
Zurück zum Zitat Bozas GT, Bamias A, Kastritis E, Rodolakis A, Vlahos G, Papadimitriou CA, Markaki S, Dimopoulos MA (2005) Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus. Eur J Gynaecol Oncol 26:627–631PubMed Bozas GT, Bamias A, Kastritis E, Rodolakis A, Vlahos G, Papadimitriou CA, Markaki S, Dimopoulos MA (2005) Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus. Eur J Gynaecol Oncol 26:627–631PubMed
3.
Zurück zum Zitat Chambers JT, Merino M, Kohorn EI (1987) Uterine papillary serous carcinoma. Obstet Gynecol 69:109–113PubMed Chambers JT, Merino M, Kohorn EI (1987) Uterine papillary serous carcinoma. Obstet Gynecol 69:109–113PubMed
4.
Zurück zum Zitat Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML (2003) Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 90:181–185PubMedCrossRef Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML (2003) Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 90:181–185PubMedCrossRef
5.
Zurück zum Zitat Dietrich CS 3rd, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR Jr (2005) The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol 99:557–563PubMedCrossRef Dietrich CS 3rd, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR Jr (2005) The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol 99:557–563PubMedCrossRef
6.
Zurück zum Zitat Gitsch G, Friedlander ML, Wain GV (1995) Uterine papillary serous carcinoma. A clinical study. Cancer 75:2239–2243PubMedCrossRef Gitsch G, Friedlander ML, Wain GV (1995) Uterine papillary serous carcinoma. A clinical study. Cancer 75:2239–2243PubMedCrossRef
7.
Zurück zum Zitat Guzin K, Tekcan C, Naki MM, Kayatas S, Zemheri E, Kanadikirik F, Berkman S (2006) Synchronous primary cancers of the endometrium and ovary: a case report. Eur J Gynaecol Oncol 27:425–428PubMed Guzin K, Tekcan C, Naki MM, Kayatas S, Zemheri E, Kanadikirik F, Berkman S (2006) Synchronous primary cancers of the endometrium and ovary: a case report. Eur J Gynaecol Oncol 27:425–428PubMed
8.
Zurück zum Zitat Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK (2005) Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 63:839–844PubMed Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK (2005) Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 63:839–844PubMed
9.
Zurück zum Zitat Hendrickson M, Ross J, Eifel P (1982) Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6:93–108PubMedCrossRef Hendrickson M, Ross J, Eifel P (1982) Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6:93–108PubMedCrossRef
10.
Zurück zum Zitat Huh WK, Powell M, Leath III CA (2003) Uterine papillary serous carcinoma. Comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 91:470–475PubMedCrossRef Huh WK, Powell M, Leath III CA (2003) Uterine papillary serous carcinoma. Comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 91:470–475PubMedCrossRef
11.
Zurück zum Zitat Jeffrey JF, Krepart GV, Lotocki RJ (1986) Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 67:670–674PubMedCrossRef Jeffrey JF, Krepart GV, Lotocki RJ (1986) Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 67:670–674PubMedCrossRef
12.
Zurück zum Zitat Jordan LB, Abdul-Kader M, Al-Nafussi A (2001) Uterine serous papillary carcinoma: histopathologic changes within the female genital tract. Int J Gynecol Cancer 11:283–289PubMedCrossRef Jordan LB, Abdul-Kader M, Al-Nafussi A (2001) Uterine serous papillary carcinoma: histopathologic changes within the female genital tract. Int J Gynecol Cancer 11:283–289PubMedCrossRef
13.
Zurück zum Zitat Lim P, Al Kushi A, Gilks B (2001) Early stage uterine papillary serous carcinoma of the endometrium Effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 91:752–757PubMedCrossRef Lim P, Al Kushi A, Gilks B (2001) Early stage uterine papillary serous carcinoma of the endometrium Effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 91:752–757PubMedCrossRef
14.
Zurück zum Zitat Mallipeddi P, Kapp DS, Teng NN (1993) Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer 71:3076–3381PubMedCrossRef Mallipeddi P, Kapp DS, Teng NN (1993) Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer 71:3076–3381PubMedCrossRef
15.
Zurück zum Zitat Nguyen NP, Sallah S, Karlsson U, Vos P, Ludin A, Semer D, Tait D, Salehpour M, Jendrasiak G, Robiou C (2001) Prognosis for papillary serous carcinoma of the endometrium after surgical staging. Int J Gynecol Cancer 11:305–311PubMedCrossRef Nguyen NP, Sallah S, Karlsson U, Vos P, Ludin A, Semer D, Tait D, Salehpour M, Jendrasiak G, Robiou C (2001) Prognosis for papillary serous carcinoma of the endometrium after surgical staging. Int J Gynecol Cancer 11:305–311PubMedCrossRef
16.
Zurück zum Zitat Rosenberg P, Boeryd B, Simonsen E (1993) A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol l48:32–37CrossRef Rosenberg P, Boeryd B, Simonsen E (1993) A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol l48:32–37CrossRef
17.
Zurück zum Zitat Slomovitz BM, Burke TW, Eifel PJ (2003) Uterine papillary serous carcinoma (UPSC). A single institution review of 129 cases. Gynecol Oncol 91:463–469PubMedCrossRef Slomovitz BM, Burke TW, Eifel PJ (2003) Uterine papillary serous carcinoma (UPSC). A single institution review of 129 cases. Gynecol Oncol 91:463–469PubMedCrossRef
18.
Zurück zum Zitat Smith RS, Kapp DS, Chen Q (2000) Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys 48:767–778PubMed Smith RS, Kapp DS, Chen Q (2000) Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys 48:767–778PubMed
Metadaten
Titel
Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report
verfasst von
Seiji Kanayama
Yoshihiko Yamada
Shoji Haruta
Katsuhiko Naruse
Naoto Furukawa
Ryuji Kawaguchi
Shozo Yoshida
Mariko Sakata
Toshiyuki Sado
Takashi Kitanaka
Hidekazu Oi
Hiroshi Kobayashi
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2008
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-007-0550-y

Weitere Artikel der Ausgabe 3/2008

Archives of Gynecology and Obstetrics 3/2008 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.